[Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?].
Weizel
Achim
A
Diakoniekrankenhaus Mannheim.
Sawicki
Peter T
PT
D000924:Anticholesteremic Agents / Q000191:economics / Q000627:therapeutic use*; D000069059:Atorvastatin; D001384:Azetidines / Q000191:economics / Q000627:therapeutic use; D008078:Cholesterol, LDL / Q000097:blood*; D003324:Coronary Artery Disease / Q000097:blood / Q000188:drug therapy*; D003363:Cost Control; D016527:Drug Costs; D000069438:Ezetimibe; D005858:Germany; D006538:Heptanoic Acids / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D019458:Insurance Coverage / Q000191:economics; D008297:Male; D008875:Middle Aged; D009313:National Health Programs / Q000191:economics*; D011758:Pyrroles / Q000191:economics / Q000627:therapeutic use*; D019821:Simvastatin / Q000191:economics / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D001384:Azetidines; D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin; D019821:Simvastatin; D000069438:Ezetimibe